Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Thu, Feb 19th, 2026

Thu, Feb 19th, 2026

GetNews

GetNews

Most Recent Stories

Vascular Malformations Clinical Trial Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Vascular Malformations Pipeline Insight, 2026” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Vascular Malformations pipeline landscape. It...

Oncolytic Virus Cancer Therapy Clinical Trial Pipeline Appears Robust With 120+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Oncolytic Virus Cancer Therapy Pipeline Insight 2026” report provides comprehensive insights about 120+ companies and 125+ pipeline drugs in Oncolytic Virus Cancer Therapy pipeline...

Soft Tissue Sarcoma Clinical Trial Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Soft Tissue Sarcoma Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Soft Tissue Sarcoma pipeline landscape. It covers...

Charcot Marie Tooth Clinical Trial Pipeline Accelerates as 10+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Charcot Marie Tooth Disease Pipeline Insight, 2026” report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Charcot Marie Tooth Disease pipeline landscape....

Metastatic Colorectal Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 150+ Key Companies | DelveInsight

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2026” report provides comprehensive insights about 150+ companies and 180+ pipeline drugs in Metastatic Colorectal Cancer pipeline landscape....

Oral Mucositis Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Oral Mucositis Pipeline Insight 2025” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Oral Mucositis pipeline landscape. It covers the Oral...

Stargardt Disease Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Stargardt Disease Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Stargardt Disease pipeline landscape. It covers the...

Heart Failure Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Heart Failure Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Heart Failure pipeline landscape. It covers the Heart Failure...

Chronic Rhinosinusitis with Nasal Polyps Clinical Trial Pipeline Expands as 8+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Chronic Rhinosinusitis with Nasal Polyps Pipeline Insight 2026” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in the Chronic Rhinosinusitis with...

Rett Syndrome Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Rett Syndrome Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Rett Syndrome pipeline landscape. It covers the Rett Syndrome...

Author Links

Tweets @Barchart

Barchart
@Barchart
BREAKING 🚨: UnitedHealth $UNH forms a Death Cross ☠️ for the first time since January 2025 🤯 The last one sent shares plunging 57% over the next 6 months 📉📉 https://t.co/73A6IHLnzV
Barchart
@Barchart
Options Traders are the most bearish on stocks in more than 12 months after the equity put/call ratio soared to 1.28 🐻👻🤯👀 https://t.co/DgMnkNKJyP
Barchart
@Barchart
Nasdaq $QQQ Just Sent a Chilling Signal — Right Before Nvidia $NVDA Earnings 🚨 Is The Party Over? 👻https://t.co/CiDM2Us8tJ
Barchart
@Barchart
U.S. Dollar on track for its best week since October 💵🤑📈 https://t.co/te3vyqa2N7
Barchart
@Barchart
Alphabet $GOOGL fell below its 50-day moving average last week and now sits right at the 100-day 🚨 If that breaks, a return to the 200-day MA might be in play 🤯👀 https://t.co/K89Q7efcUj
Barchart
@Barchart
Crude Oil Breakout Time? 🚨 Now trading at its highest price since August 📈 https://t.co/B4xVeTw6dp
Barchart
@Barchart
JUST IN 🚨: U.S. Treasury just bought back $1.56 Billion of their own debt 🤯👀 https://t.co/DzU2ga65uy
Barchart
@Barchart
BREAKING 🚨: CocoaCocoa has now traded red for 9 consecutive days, its longest losing streak since February 2017 🍫📉 https://t.co/1jj8eZuIeb
Barchart
@Barchart
Source: @VisualCap
Barchart
@Barchart
Biggest Buyers and Sellers of U.S. Debt 🚨 https://t.co/k5yOSskooh
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar